Szerző: " Kollaborációs szervezet: TENAYA and LUCERNE Investigators"

Arshad M Khanani; Aachal Kotecha; Andrew Chang; Shih-Jen Chen; Youxin Chen; Robyn Guymer; Jeffrey S Heier; Frank G Holz; Tomohiro Iida; Jane A Ives; Jennifer I Lim; Hugh Lin; Stephan Michels; Carlos Quezada Ruiz; Ursula Schmidt-Erfurth; David Silverman; Rishi Singh; Balakumar Swaminathan; Jeffrey R Willis; Ramin Tadayoni; Kollaborációs szervezet: TENAYA and LUCERNE Investigators; Tóth-Molnár Edit; et al.: TENAYA and LUCERNE : Two-Year Results from the Phase 3 Neovascular Age-Related Macular Degeneration Trials of Faricimab with Treat-and-Extend Dosing in Year 2.
OPHTHALMOLOGY, 131 (8). pp. 914-926. ISSN 0161-6420 (2024)

Heier Jeffrey S.; Khanani Arshad M.; Ruiz Carlos Quezada; Basu Karen; Ferrone Philip J.; Brittain Christopher; Figueroa Marta S.; Lin Hugh; Holz Frank G.; Patel Vaibhavi; Lai Timothy Y. Y.; Silverman David; Tóth-Molnár Edit; Zatorska Barbara; Kollaborációs szervezet: TENAYA and LUCERNE Investigators: Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials.
LANCET, 399 (10326). pp. 729-740. ISSN 0140-6736 (2022)